Spasticity.
作者信息
Rush Raphael, Kumbhare Dinesh
机构信息
Department of Internal Medicine (Rush), University of Toronto; Department of Physical Medicine and Rehabilitation, Toronto Rehabilitation Institute, and University of Toronto (Kumbhare), Toronto, Ont.
出版信息
CMAJ. 2015 Apr 7;187(6):436. doi: 10.1503/cmaj.140405. Epub 2014 Nov 17.
Abstract
摘要
相似文献
1
Spasticity.痉挛
CMAJ. 2015 Apr 7;187(6):436. doi: 10.1503/cmaj.140405. Epub 2014 Nov 17.
2
Botulinum toxin and spasticity.肉毒杆菌毒素与痉挛
J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):143-7. doi: 10.1136/jnnp.69.2.143.
3
The management of cerebral palsy: subjectivity and a conundrum.脑瘫的管理：主观性与难题
J Child Neurol. 1996 Mar;11(2):75-76. doi: 10.1177/088307389601100201.
4
The use of botulinum toxin and intrathecal baclofen in hip dysplasia in cerebral palsy.肉毒杆菌毒素和鞘内注射巴氯芬在脑瘫患儿髋关节发育不良中的应用
Dev Med Child Neurol. 2023 Aug;65(8):1125. doi: 10.1111/dmcn.15642. Epub 2023 May 20.
5
[Treatment of spasticity].[痉挛的治疗]
Duodecim. 1999;115(8):877-85.
6
New approaches to managing spasticity in children with cerebral palsy.治疗脑瘫患儿痉挛状态的新方法。
West J Med. 1997 Apr;166(4):271.
7
Spasticity in children and young people with non-progressive brain disorders: summary of NICE guidance.患有非进行性脑部疾病的儿童和青少年的痉挛状态：英国国家卫生与临床优化研究所指南摘要
BMJ. 2012 Jul 26;345:e4845. doi: 10.1136/bmj.e4845.
8
Pharmacologic interventions for reducing spasticity in cerebral palsy.用于降低脑瘫患者痉挛状态的药物干预措施。
Indian J Pediatr. 2005 Oct;72(10):869-72. doi: 10.1007/BF02731118.
9
[Spasticity in children cerebral palsy: diagnosis and treatment strategies].[小儿脑性瘫痪中的痉挛状态：诊断与治疗策略]
Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(7 Pt 2):24-8.
10
The treatment of cerebral palsy: What we know, what we don't know.脑瘫的治疗：我们所知道的与我们所不知道的。
J Pediatr. 2004 Aug;145(2 Suppl):S42-6. doi: 10.1016/j.jpeds.2004.05.022.
引用本文的文献
1
Current techniques for the treatment of spasticity and their effectiveness.目前治疗痉挛的技术及其有效性。
EFORT Open Rev. 2025 May 5;10(5):237-249. doi: 10.1530/EOR-2024-0156.
2
Efficacy of botulinum toxin A combined with extracorporeal shockwave therapy in post-stroke spasticity: a systematic review.A型肉毒毒素联合体外冲击波疗法治疗脑卒中后痉挛的疗效：一项系统评价
Front Neurol. 2024 Mar 15;15:1342545. doi: 10.3389/fneur.2024.1342545. eCollection 2024.
本文引用的文献
1
The efficacy of Botulinum Toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach.A型肉毒毒素治疗成人痉挛和疼痛的疗效：使用推荐分级的评估、制定与评价方法进行的系统评价和荟萃分析。
Clin Rehabil. 2013 Dec;27(12):1084-96. doi: 10.1177/0269215513491274. Epub 2013 Jul 17.
2
Revisiting physiologic and psychologic triggers that increase spasticity.重新审视增加痉挛的生理和心理触发因素。
Am J Phys Med Rehabil. 2013 Apr;92(4):357-69. doi: 10.1097/phm.0b013e31827d68a4.
3
Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.当代上肢卒中后痉挛的药物治疗：系统评价。
Clin Ther. 2010 Dec;32(14):2282-303. doi: 10.1016/j.clinthera.2011.01.005.
4
Time-course and determinants of spasticity during the first six months following first-ever stroke.首次中风后最初 6 个月痉挛的时间进程和决定因素。
J Rehabil Med. 2010 Apr;42(4):296-301. doi: 10.2340/16501977-0509.
5
Prevalence of cerebral palsy in 8-year-old children in three areas of the United States in 2002: a multisite collaboration.2002年美国三个地区8岁儿童脑瘫患病率：一项多地点合作研究
Pediatrics. 2008 Mar;121(3):547-54. doi: 10.1542/peds.2007-1270.
6
Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review.非进行性神经疾病中的口服抗痉挛药物：一项系统评价
Neurology. 2004 Oct 26;63(8):1357-63. doi: 10.1212/01.wnl.0000141863.52691.44.
7
Prevalence and treatment of spasticity reported by multiple sclerosis patients.多发性硬化症患者报告的痉挛发生率及治疗情况。
Mult Scler. 2004 Oct;10(5):589-95. doi: 10.1191/1352458504ms1085oa.
8
Anti-spasticity agents for multiple sclerosis.用于治疗多发性硬化症的抗痉挛药物。
Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332.
9
Epidemiology of spasticity following traumatic spinal cord injury.
Arch Phys Med Rehabil. 1990 Jul;71(8):566-9.
Zotero 插件